Gene therapy in PIDs, hemoglobin, ocular, neurodegenerative, and hemophilia B disorders
A new approach is adopted to treat primary immunodeficiency disorders, such as the severe combined immunodeficiency (SCID; e.g., adenosine deaminase SCID [ADA-SCID] and IL-2 receptor X-linked severe combined immunodeficiency [SCID-X1]). The success, along with the feasibility of gene therapy, is und...
Na minha lista:
| Principais autores: | , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
De Gruyter
2021-05-01
|
| Serier: | Open Life Sciences |
| Fag: | |
| Online adgang: | https://doi.org/10.1515/biol-2021-0033 |
| Tags: |
Ingen Tags, Vær først til at tagge denne postø!
|